Article
Author(s):
Fort Lauderdale, FL-Bimatoprost appears to have greater IOP-lowering effectiveness than travoprost in patients with primary open-angle glaucoma (POAG) or ocular hypertension, according to a small pilot study.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.